The contributions of focused attention and open monitoring in mindfulness-based cognitive therapy for affective disturbances: A 3-armed randomized dismantling trial

Brendan Cullen, Kristina Eichel, Jared R Lindahl, Hadley Rahrig, Nisha Kini, Julie Flahive, Willoughby B Britton, Brendan Cullen, Kristina Eichel, Jared R Lindahl, Hadley Rahrig, Nisha Kini, Julie Flahive, Willoughby B Britton

Abstract

Objective: Mindfulness-based cognitive therapy (MBCT) includes a combination of focused attention (FA) and open monitoring (OM) meditation practices. The aim of this study was to assess both short- and long-term between- and within-group differences in affective disturbance among FA, OM and their combination (MBCT) in the context of a randomized controlled trial.

Method: One hundred and four participants with mild to severe depression and anxiety were randomized into one of three 8-week interventions: MBCT (n = 32), FA (n = 36) and OM (n = 36). Outcome measures included the Inventory of Depressive Symptomatology (IDS), and the Depression Anxiety Stress Scales (DASS). Mixed effects regression models were used to assess differential treatment effects during treatment, post-treatment (8 weeks) and long-term (20 weeks). The Reliable Change Index (RCI) was used to translate statistical findings into clinically meaningful improvements or deteriorations.

Results: All treatments demonstrated medium to large improvements (ds = 0.42-1.65) for almost all outcomes. While all treatments were largely comparable in their effects at post-treatment (week 8), the treatments showed meaningful differences in rapidity of response and pattern of deteriorations. FA showed the fastest rate of improvement and the fewest deteriorations on stress, anxiety and depression during treatment, but a loss of treatment-related gains and lasting deteriorations in depression at week 20. OM showed the slowest rate of improvement and lost treatment-related gains for anxiety, resulting in higher anxiety in OM at week 20 than MBCT (d = 0.40) and FA (d = 0.36), though these differences did not reach statistical significance after correcting for multiple comparisons (p's = .06). MBCT and OM showed deteriorations in stress, anxiety and depression at multiple timepoints during treatment, with lasting deteriorations in stress and depression. MBCT showed the most favorable pattern for long-term treatment of depression.

Conclusions: FA, OM and MBCT show different patterns of response for different dimensions of affective disturbance.

Trial registration: This trial is registered at (v NCT01831362); www.clinicaltrials.gov.

Conflict of interest statement

The authors have read the journal’s policy and have the following competing interests: WBB is a MBSR and MBCT teacher and has received financial compensation for this role, and is also nominally affiliated with the Mindfulness Center at Brown University which generates income by offering mindfulness classes to the public. WBB is the founder of Cheetah House, a RI non-profit organization that provides information about meditation-related difficulties, individual consultations, and support groups, as well as educational trainings to meditation teachers, clinicians, educators and mindfulness providers. This interest has been disclosed to and is being managed by Brown University, in accordance with its Conflict of Interest and Conflict of Commitment policies. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1. Participant flow.
Fig 1. Participant flow.
FA = Focused attention; MBCT = Mindfulness-based cognitive therapy; OM = Open monitoring.
Fig 2. Differential treatment effects and clinically…
Fig 2. Differential treatment effects and clinically significant change in depression (IDS) for all three treatments over time.
(a) Group means (symbol) and standard error (error bars) at baseline (week 0), post-treatment (week 8) and follow-up (week 20) in intent-to-treat regression analysis (n = 104). (b) Reliable change index (RCI) at each timepoint relative to baseline scores. Upward and downward bars signify % of each treatment sample showing clinically significant improvements and deteriorations, respectively. Percent of sample with no reliable change is not shown (see S1 Appendix).
Fig 3. Differential treatment effects and clinically…
Fig 3. Differential treatment effects and clinically significant changes in stress, anxiety and depression (DASS).
(a,c,e) Group means (symbol) and standard error (error bars) at weeks 0, 2, 4, 6, 8 and 20 in intent-to-treat regression analysis (n = 104). Gray text boxes denote statistically meaningful between-group differences (d > 0.30). (b,d,f) Reliable change index (RCI) at each timepoint relative to baseline scores. Upward and downward bars signify % of each treatment sample showing clinically significant improvements and deteriorations, respectively. Percent of sample with no reliable change is not shown (see S1 Appendix).
Fig 4. Number of weeks until first…
Fig 4. Number of weeks until first significant improvement (FSI) from baseline in stress, anxiety and depression (DASS) during the 8-week intervention.

References

    1. Morone NE, Moore CG, Greco CM. Characteristics of Adults Who Used Mindfulness Meditation: United States, 2012. J Altern Complement Med. 2017;23(7):545–50. Epub 2017/01/14. 10.1089/acm.2016.0099
    1. Ospina MB, Bond K, Karkhaneh M, Tjosvold L, Vandermeer B, Liang Y, et al. Meditation practices for health: state of the research. Evidence Report/Technology Assessment No 155 AHQR Publication No 07-E010 Rockville MD: Agency for Healthcare Research and Quality. 2007;(155):1–263.
    1. Van Dam NT, van Vugt MK, Vago DR, Schmalzl L, Saron CD, Olendzki A, et al. Mind the Hype: A Critical Evaluation and Prescriptive Agenda for Research on Mindfulness and Meditation. Perspect Psychol Sci. 2018;13(1):36–61. Epub 2017/10/11. 10.1177/1745691617709589
    1. Davidson RJ. Empirical explorations of mindfulness: conceptual and methodological conundrums. Emotion. 2010;10(1):8–11. Epub 2010/02/10. 10.1037/a0018480
    1. Segal ZV, Williams JM, Teasdale JD. Mindfulness-based cognitive therapy for depression: a new approach to preventing relapse. London: Guilford; 2002.
    1. Crane R. Mindfulness-based cognitive therapy: Distinctive features. New York: Routledge; 2013.
    1. Lutz A, Slagter HA, Dunne JD, Davidson RJ. Attention regulation and monitoring in meditation. Trends Cogn Sci. 2008;12(4):163–9. 10.1016/j.tics.2008.01.005
    1. Santorelli S, Meleo-Meyer F, Koerbel L, Kabat-Zinn J, Blacker M, Herbette G, et al. Mindfulness-Based Stress Reduction (MBSR) Authorized Curriculum Guide. Center for Mindfulness in Medicine, Health Care, and Society (CFM), University of Massachusetts Medical School. 2017.
    1. Lichtenstein-Vidne L, Okon-Singer H, Cohen N, Todder D, Aue T, Nemets B, et al. Attentional bias in clinical depression and anxiety: The impact of emotional and non-emotional distracting information. Biol Psychol. 2017;122:4–12. Epub 2016/07/17. 10.1016/j.biopsycho.2016.07.012
    1. Cisler JM, Koster EH. Mechanisms of attentional biases towards threat in anxiety disorders: An integrative review. Clin Psychol Rev. 2010;30(2):203–16. Epub 2009/12/17. 10.1016/j.cpr.2009.11.003
    1. Brake CA, Sauer-Zavala S, Boswell JF, Gallagher MW, Farchione TJ, Barlow DH. Mindfulness-Based Exposure Strategies as a Transdiagnostic Mechanism of Change: An Exploratory Alternating Treatment Design. Behav Ther. 2016;47(2):225–38. 10.1016/j.beth.2015.10.008
    1. Uusberg H, Uusberg A, Talpsep T, Paaver M. Mechanisms of mindfulness: The dynamics of affective adaptation during open monitoring. Biol Psychol. 2016;118:94–106. 10.1016/j.biopsycho.2016.05.004
    1. Crane RS, Brewer J, Feldman C, Kabat-Zinn J, Santorelli S, Williams JM, et al. What defines mindfulness-based programs? The warp and the weft. Psychol Med. 2017;47(6):990–9. Epub 2016/12/30. 10.1017/S0033291716003317
    1. Marzetti L, Di Lanzo C, Zappasodi F, Chella F, Raffone A, Pizzella V. Magnetoencephalographic alpha band connectivity reveals differential default mode network interactions during focused attention and open monitoring meditation. Front Hum Neurosci. 2014;8 10.3389/fnhum.2014.00008
    1. Hasenkamp W, Wilson-Mendenhall CD, Duncan E, Barsalou LW. Mind wandering and attention during focused meditation: a fine-grained temporal analysis of fluctuating cognitive states. Neuroimage. 2012;59(1):750–60. 10.1016/j.neuroimage.2011.07.008
    1. Shankman R. The experience of samadhi: An in-depth exploration of Buddhist meditation: Shambala Publications; 2008.
    1. Britton WB, Davis JH, Loucks EB, Peterson B, Cullen BH, Reuter L, et al. Dismantling Mindfulness-Based Cognitive Therapy: Creation and validation of 8-week focused attention and open monitoring interventions within a 3-armed randomized controlled trial. Behav Res Ther. 2018;101:92–107. Epub 2017/11/07. 10.1016/j.brat.2017.09.010
    1. Guidi J, Brakemeier EL, Bockting CLH, Cosci F, Cuijpers P, Jarrett RB, et al. Methodological Recommendations for Trials of Psychological Interventions. Psychother Psychosom. 2018;87(5):276–84. Epub 2018/07/17. 10.1159/000490574
    1. IOM. Knowing What Works in Health Care: A Roadmap for the Nation. Washington, DC: Institute of Medicine. National Academies Press; 2008.
    1. Dimidjian S, Segal ZV. Prospects for a clinical science of mindfulness-based intervention. Am Psychol. 2015;70(7):593–620. Epub 2015/10/06. 10.1037/a0039589
    1. Lutz W, Stulz N, Kock K. Patterns of early change and their relationship to outcome and follow-up among patients with major depressive disorders. J Affect Disord. 2009;118(1–3):60–8. 10.1016/j.jad.2009.01.019
    1. Lutz W, Hofmann SG, Rubel J, Boswell JF, Shear MK, Gorman JM, et al. Patterns of early change and their relationship to outcome and early treatment termination in patients with panic disorder. J Consult Clin Psychol. 2014;82(2):287–97. 10.1037/a0035535
    1. Aderka IM, Nickerson A, Boe HJ, Hofmann SG. Sudden gains during psychological treatments of anxiety and depression: a meta-analysis. J Consult Clin Psychol. 2012;80(1):93–101. 10.1037/a0026455
    1. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991;59(1):12–9. Epub 1991/02/01. 10.1037//0022-006x.59.1.12
    1. Wampold BE, Mondin GW, Moody M, Stich F, Benson K, Ahn H. A meta-analysis of outcome studies comparing bona fide psychotherapies: Empiricially, "all must have prizes.". Psychol Bull. 1997;122(3):203–15.
    1. Shahar B, Britton WB, Sbarra DA, Figueredo AJ, Bootzin RR. Mechanisms of change in mindfulness-based cognitive therapy for depression: Preliminary evidence from a randomized controlled trial. Int J Cogn Ther. 2010;3(4):402–18.
    1. Kabat-Zinn J. Full catastrophe living: Using the wisdom of your body and mind to face stress, pain, and illness: Delta; 1990.
    1. Beck A, Rush T, Shaw JF, Emery G. Cognitive therapy of depression. New York: Guilford Press; 1979.
    1. Segal ZV, Teasdale JD, Williams JM, Gemar MC. The Mindfulness-Based Cognitive Therapy Adherence Scale: Inter-rater realiability, adherence to and treatment distintiveness. Clin Psychol Psychother. 2002;9:131–8.
    1. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med. 1996;26(3):477–86. 10.1017/s0033291700035558
    1. Lovibond PF, Lovibond SH. The Structure of Negative Emotional States—Comparison of the Depression Anxiety Stress Scales (Dass) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995;33(3):335–43. 10.1016/0005-7967(94)00075-u
    1. Crawford JR, Henry JD. The Depression Anxiety Stress Scales (DASS): normative data and latent structure in a large non-clinical sample. Br J Clin Psychol. 2003;42(Pt 2):111–31. 10.1348/014466503321903544
    1. Brown TA, Chorpita BF, Korotitsch W, Barlow DH. Psychometric properties of the Depression Anxiety Stress Scales (DASS) in clinical samples. Behav Res Ther. 1997;35(1):79–89. 10.1016/s0005-7967(96)00068-x
    1. Cohen BH. Explaining psychological statistics. 4th ed. Hoboken, NJ: John Wiley & Sons; 2013.
    1. Cumming G. The new statistics: why and how. Psychol Sci. 2014;25(1):7–29. Epub 2013/11/14. 10.1177/0956797613504966
    1. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869 Epub 2010/03/25. 10.1136/bmj.c869
    1. Wasserstein R, Schirm AL, Lazar NA. Moving to a world beyond “p < 0.05”. The American Statisitician. 2019;73:1–19. 10.1080/00031305.2019.1583913
    1. Wasserstein R, Lazar NA. The ASA’s Statement on p-Values: Context, Process, and Purpose. The American Statistician. 2016;70:129–33. 10.1080/00031305.2016.1154108
    1. Keefe RS, Kraemer HC, Epstein RS, Frank E, Haynes G, Laughren TP, et al. Defining a clinically meaningful effect for the design and interpretation of randomized controlled trials. Innov Clin Neurosci. 2013;10(5–6 Suppl A):4S–19S. Epub 2013/07/25.
    1. Rosenthal R. Meta-analytic procedures for social research. Newbury Park, CA: Sage; 1991.
    1. Lakens D. Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol. 2013;4:863 Epub 2013/12/11. 10.3389/fpsyg.2013.00863
    1. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc. 1995;57:289–300. 10.1111/j.2517-6161.1995.tb02031.x
    1. Jacobson NS, Roberts LJ, Berns SB, McGlinchey JB. Methods for defining and determining the clinical significance of treatment effects: description, application, and alternatives. J Consult Clin Psychol. 1999;67(3):300–7. Epub 1999/06/16. 10.1037//0022-006x.67.3.300
    1. Jacobson NS, Dobson KS, Traux PA, Addis ME, Koerner K, Gollan JK, et al. A component analysis of cognitive-behavioral treatment for depression. J Consult Clin Psychol. 1996;64(2):295–304. 10.1037//0022-006x.64.2.295
    1. Goyal M, Singh S, Sibinga EM, Gould NF, Rowland-Seymour A, Sharma R, et al. Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Intern Med. 2014;174(3):357–68. 10.1001/jamainternmed.2013.13018
    1. Strauss C, Cavanagh K, Oliver A, Pettman D. Mindfulness-based interventions for people diagnosed with a current episode of an anxiety or depressive disorder: a meta-analysis of randomised controlled trials. PLoS One. 2014;9(4):e96110 10.1371/journal.pone.0096110
    1. Tickell A, Ball S, Bernard P, Kuyken W, Marx R, Pack S, et al. The Effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) in Real-World Healthcare Services. Mindfulness. 2019. 10.1007/s12671-018-1087-9
    1. van Aalderen JR, Donders AR, Giommi F, Spinhoven P, Barendregt HP, Speckens AE. The efficacy of mindfulness-based cognitive therapy in recurrent depressed patients with and without a current depressive episode: a randomized controlled trial. Psychol Med. 2012;42(5):989–1001. Epub 2011/10/25. 10.1017/S0033291711002054
    1. Britton WB. Can mindfulness be too much of a good thing? The value of a middle way. Curr Opin Psychol. 2019;28:159–65. Epub 2019/02/02. 10.1016/j.copsyc.2018.12.011
    1. Kuyken W, Warren FC, Taylor RS, Whalley B, Crane C, Bondolfi G, et al. Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse: An Individual Patient Data Meta-analysis From Randomized Trials. JAMA Psychiatry. 2016;73(6):565–74. 10.1001/jamapsychiatry.2016.0076
    1. Onken LS, Carroll KM, Shoham V, Cuthbert BN, Riddle M. Reenvisioning Clinical Science: Unifying the Discipline to Improve the Public Health. Clin Psychol Sci. 2014;2(1):22–34. 10.1177/2167702613497932
    1. Lutz A, Dunne JD, Davidson RJ. Meditation and the neuroscience of consciousness: An introduction In: Zelazo P, Moscovitch M, Thompson E, editors. The Cambridge Handbook of Consciousness. New York: Cambridge University Press; 2007. p. 499–553.
    1. McNally RJ. Attentional bias for threat: Crisis or opportunity? Clin Psychol Rev. 2018. Epub 2018/06/02. 10.1016/j.cpr.2018.05.005
    1. Wells TT, Beevers CG, Robison AE, Ellis AJ. Gaze behavior predicts memory bias for angry facial expressions in stable dysphoria. Emotion. 2010;10(6):894–902. Epub 2010/11/10. 10.1037/a0020022
    1. Hallion LS, Ruscio AM. A meta-analysis of the effect of cognitive bias modification on anxiety and depression. Psychol Bull. 2011;137(6):940–58. Epub 2011/07/07. 10.1037/a0024355
    1. Armstrong T, Olatunji BO. Eye tracking of attention in the affective disorders: a meta-analytic review and synthesis. Clin Psychol Rev. 2012;32(8):704–23. Epub 2012/10/13. 10.1016/j.cpr.2012.09.004
    1. Barry TJ, Vervliet B, Hermans D. An integrative review of attention biases and their contribution to treatment for anxiety disorders. Front Psychol. 2015;6:968 Epub 2015/07/29. 10.3389/fpsyg.2015.00968
    1. Khoury B, Lecomte T, Fortin G, Masse M, Therien P, Bouchard V, et al. Mindfulness-based therapy: a comprehensive meta-analysis. Clin Psychol Rev. 2013;33(6):763–71. 10.1016/j.cpr.2013.05.005
    1. Goldberg SB, Tucker RP, Greene PA, Davidson RJ, Wampold BE, Kearney DJ, et al. Mindfulness-based interventions for psychiatric disorders: A systematic review and meta-analysis. Clin Psychol Rev. 2018;59:52–60. Epub 2017/11/12. 10.1016/j.cpr.2017.10.011
    1. Hofmann SG, Sawyer AT, Witt AA, Oh D. The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review. J Consult Clin Psychol. 2010;78(2):169–83. 10.1037/a0018555
    1. Huijbers M, Crane R, Kuyken, Heijke L, van den Hout I, Donders A, et al. Teacher Competence in Mindfulness-Based Cognitive Therapy for Depression and Its Relation to Treatment Outcome. Mindfulness 2017;Jan 12 online.
    1. Mason L, Grey N, Veale D. My Therapist is a Student? The Impact of Therapist Experience and Client Severity on Cognitive Behavioural Therapy Outcomes for People with Anxiety Disorders. Behav Cogn Psychother. 2016;44(2):193–202. 10.1017/S1352465815000065
    1. Norcross JC, Wampold BE. Evidence-based therapy relationships: research conclusions and clinical practices. Psychotherapy (Chic). 2011;48(1):98–102. 10.1037/a0022161
    1. Cuijpers P, Li J, Hofmann SG, Andersson G. Self-reported versus clinician-rated symptoms of depression as outcome measures in psychotherapy research on depression: a meta-analysis. Clin Psychol Rev. 2010;30(6):768–78. Epub 2010/07/14. 10.1016/j.cpr.2010.06.001
    1. Krumpal I. Determinants of social desirability bias in sensitive surveys: A literature review. Quality & Quantity: International Journal of Methodology. 2013;47:2025–47. 10.1007/s11135-011-9640-9.
    1. Dimidjian S, Hollon SD. How would we know if psychotherapy were harmful? Am Psychol. 2010;65(1):21–33. 10.1037/a0017299
    1. Gombrich R. Retracing an ancient debate: How insight worsted concentration in the Pali Canon. How Buddhism began: the conditioned genesis of the early teachings. London: Athlone Press; 1996. 10.1159/000333581
    1. Kuyken W, Crane W, Williams JM. Mindfulness-Based Cognitive Therapy (MBCT) Implementation Resources. Oxford University, University of Exeter, Bangor University; 2012.

Source: PubMed

3
Abonnieren